1 - 25 of
209
results
for author:"Miller W."
in Literature Citations
| Complete nucleotide sequences of the small and medium RNA genome segments of Kairi virus (family Bunyaviridae). Soto V., Dorman K.S., Miller W.A., Farfan-Ale J.A., Lorono-Pino M.A., Garcia-Rejon J.E., Blitvich B.J. Arch. Virol. 154:1555-1558(2009) · UniProtKB (4) |
| Analysis of complete mitochondrial genomes from extinct and extant rhinoceroses reveals lack of phylogenetic resolution. Willerslev E., Gilbert M.T., Binladen J., Ho S.Y., Campos P.F., Ratan A., Tomsho L.P., da Fonseca R.R., Sher A., Kuznetsova T.V. et al. BMC Evol. Biol. 9:95-95(2009) · UniProtKB (52) |
| Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Shenoy S.K., Modi A.S., Shukla A.K., Xiao K., Berthouze M., Ahn S., Wilkinson K.D., Miller W.E., Lefkowitz R.J. Proc. Natl. Acad. Sci. U.S.A. 106:6650-6655(2009) · UniProtKB (3) · Mapped (33) |
| Aminofurazans as potent inhibitors of AKT kinase. Rouse M.B., Seefeld M.A., Leber J.D., McNulty K.C., Sun L., Miller W.H., Zhang S., Minthorn E.A., Concha N.O., Choudhry A.E. et al. Bioorg. Med. Chem. Lett. 19:1508-1511(2009) · Mapped (2) |
| Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Ranadive S.A., Ersoy B., Favre H., Cheung C.C., Rosenthal S.M., Miller W.L., Vaisse C. Clin. Endocrinol. (Oxf) 71:388-393(2009) · Mapped (2) |
| The mitochondrial genome sequence of the Tasmanian tiger (Thylacinus cynocephalus). Miller W., Drautz D.I., Janecka J.E., Lesk A.M., Ratan A., Tomsho L.P., Packard M., Zhang Y., McClellan L.R., Qi J. et al. Genome Res. 19:213-220(2009) · UniProtKB (26) |
| A crystallographic snapshot of tyrosine trans-phosphorylation in action. Chen H., Xu C.F., Ma J., Eliseenkova A.V., Li W., Pollock P.M., Pitteloud N., Miller W.T., Neubert T.A., Mohammadi M. Proc. Natl. Acad. Sci. U.S.A. 105:19660-19665(2008) · Mapped (12) |
| Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. Gomes L.G., Huang N., Agrawal V., Mendonca B.B., Bachega T.A., Miller W.L. J. Clin. Endocrinol. Metab. 94:89-95(2009) · Mapped (11) |
| Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial. Ellis M.J., Miller W.R., Tao Y., Evans D.B., Chaudri Ross H.A., Miki Y., Suzuki T., Sasano H. Breast Cancer Res. Treat. 116:371-378(2009) · Mapped (9) |
| Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Xiang B., Chatti K., Qiu H., Lakshmi B., Krasnitz A., Hicks J., Yu M., Miller W.T., Muthuswamy S.K. Proc. Natl. Acad. Sci. U.S.A. 105:12463-12468(2008) · Mapped (17) |
| The complete genome sequence and analysis of the human pathogen Campylobacter lari. Miller W.G., Wang G., Binnewies T.T., Parker C.T. Foodborne Pathog. Dis. 5:371-386(2008) · UniProtKB (1,545) |
| Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Ji Y., Olson J., Zhang J., Hildebrandt M., Wang L., Ingle J., Fredericksen Z., Sellers T., Miller W., Dixon J.M. et al. Cancer Res. 68:5997-6005(2008) · Mapped (7) |
| Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor. Wu J., Li W., Craddock B.P., Foreman K.W., Mulvihill M.J., Ji Q.S., Miller W.T., Hubbard S.R. EMBO J. 27:1985-1994(2008) · Mapped (4) |
| Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. Hershkovitz E., Parvari R., Wudy S.A., Hartmann M.F., Gomes L.G., Loewental N., Miller W.L. J. Clin. Endocrinol. Metab. 93:3584-3588(2008) · Mapped (10) |
| Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19. Agrawal V., Huang N., Miller W.L. Pharmacogenet. Genomics 18:569-576(2008) · Mapped (15) |
| Glutathione S-transferase variants and hypertension. Delles C., Padmanabhan S., Lee W.K., Miller W.H., McBride M.W., McClure J.D., Brain N.J., Wallace C., Marcano A.C., Schmieder R.E. et al. J. Hypertens. 26:1343-1352(2008) · Mapped (19) |
| Intraspecific phylogenetic analysis of Siberian woolly mammoths using complete mitochondrial genomes. Gilbert M.T., Drautz D.I., Lesk A.M., Ho S.Y., Qi J., Ratan A., Hsu C.H., Sher A., Dalen L., Gotherstrom A. et al. Proc. Natl. Acad. Sci. U.S.A. 105:8327-8332(2008) · UniProtKB (44) |
| Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature. Benest A.V., Stone O.A., Miller W.H., Glover C.P., Uney J.B., Baker A.H., Harper S.J., Bates D.O. Arterioscler. Thromb. Vasc. Biol. 28:1462-1468(2008) · Mapped (15) |
| An overlapping essential gene in the Potyviridae. Chung B.Y.-W., Miller W.A., Atkins J.F., Firth A.E. Proc. Natl. Acad. Sci. U.S.A. 105:5897-5902(2008) · UniProtKB (2) |
| The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency. Gomes L.G., Huang N., Agrawal V., Mendonca B.B., Bachega T.A., Miller W.L. J. Clin. Endocrinol. Metab. 93:2913-2916(2008) · Mapped (46) |
| Tumor suppressor protein p53 regulates megakaryocytic polyploidization and apoptosis. Fuhrken P.G., Apostolidis P.A., Lindsey S., Miller W.M., Papoutsakis E.T. J. Biol. Chem. 283:15589-15600(2008) · Mapped (48) |
| Rose spring dwarf-associated virus has RNA structural and gene-expression features like those of Barley yellow dwarf virus. Salem N.M., Miller W.A., Rowhani A., Golino D.A., Moyne A.L., Falk B.W. Virology 375:354-360(2008) · UniProtKB (8) |
| The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans. JGI Sequencing Nature 451:783-788(2008) · UniProtKB (9,156) |
| Genetic and clinical features of p450 oxidoreductase deficiency. Scott R.R., Miller W.L. Horm. Res. 69:266-275(2008) · Mapped (10) |
| Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein. Bose M., Whittal R.M., Miller W.L., Bose H.S. J. Biol. Chem. 283:8837-8845(2008) · Mapped (6) |
